Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Association × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Trastuzumab 85 Cyclophosphamide 67 Capecitabine 67 Paclitaxel 63 Docetaxel 57 Fulvestrant 52 Letrozole 50 Carboplatin 41 pembrolizumab 39 Lapatinib 37 Doxorubicin 36 Anastrozole 32 Vinorelbine 31 Bevacizumab 30 exemestane 28 Tamoxifen 25 Gemcitabine 25 Albumin-Bound Paclitaxel 25 Radiotherapy 21 Taxes 18 atezolizumab 17 Everolimus 17 130-nm albumin-bound paclitaxel 17 pertuzumab 16 Epirubicin 16 palbociclib 15 eribulin 14 Magnetic Resonance Spectroscopy 14 Ado-Trastuzumab Emtansine 14 abemaciclib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01613482 2026-03-16

TSARINE

Centre Oscar Lambret

Phase 3 Terminated

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡